InsidersTradesSigma
Follow the Rays Company(Hong Kong)Limited share price and the full management transaction log of the company, a publicly traded company based in Japan. Shares are quoted on the JP market, under the supervision of EDINET (Japan FSA). Operating in the Health Care sector, Rays Company(Hong Kong)Limited has logged 1 public disclosures. Market capitalisation: €6.1bn. The latest transaction was disclosed on 11 November 2022 (Holding update). All data is free.
1
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Rays Company(Hong Kong)Limited Strong Buy (bullish), based on 2 analysts. Average price target: SEK 330.00.
13Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 4,438 of 29,114 companies
69.8
score / 100
Value54
Quality85
FCF yld2.6%
Earn yld3.7%
EV/EBITDA11.0x
ROE23%
Gross mgn92%
Net mgn17%
Debt/EBITDA0.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 11 November 2022
About Rays Company(Hong Kong)Limited
Rays Company (Hong Kong) Limited is a company operating in the healthcare and pharmaceutical sector. It is listed on the XTKS exchange.